A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects

– Hypoparathyroidism
– Hypercalcemia
– Kidney Failure, Chronic

Official Title

A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium


– Hypoparathyroidism- Hypercalcemia- Kidney Failure, Chronic

Study Type


Study Design

Natural History

Further Details

Study Start

Eligibility & Criteria

Ages Eligible for Study: 20 Years and above, Genders Eligible for Study: Both Criteria Subject with end stage renal disease on maintenance hemodialysis three times a week for at least 2 months prior to screening

Total Enrolment

Contact Details

[1] Creighton University, Omaha, Nebraska, 68131, United States

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.